LYTIR

Company · OTLK

Outlook Therapeutics, Inc.

Nasdaq's symbol directory lists OTLK on Nasdaq as “Outlook Therapeutics, Inc. - Common Stock”.

In the 12 months to Nov 19, 2026: insiders bought on 4 occasions (at least $2.5M); 4 filings by holders of 5% or more; 2 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $2.6M in total; Insider sales: $0 in total.Jul: Insider purchases $100KAug: Insider purchases $2.5MDecJanFebMarAprMayJunJulAugSepOctNov$2.5M
Insider purchases above the line: $2.6MInsider sales below: $0
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Ghiath M. Sukhtian bought on 1 day latest Aug 12, 2026 bought $2.5M
  2. Sukhtian Faisal Ghiath bought on 1 day latest Jul 29, 2026 bought $100K
  3. Jahr Robert Charles, Chief Executive Officer bought on 1 day latest Aug 14, 2026 value not filed
  4. KENYON LAWRENCE A, Chief Financial Officer bought on 1 day latest Aug 14, 2026 value not filed
Every trade (4)
  1. BUYJahr Robert Charles, Chief Executive Officer bought Aug 14, 2026 151,515 shares filing —
  2. BUYKENYON LAWRENCE A, Chief Financial Officer bought Aug 14, 2026 101,010 shares filing —
  3. BUYGhiath M. Sukhtian bought Aug 12, 2026 2,525,252 shares filing $2.5M
  4. BUYSukhtian Faisal Ghiath bought Jul 29, 2026 95,398 shares filing $100K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. CVI Investments, Inc. filed Nov 16, 2026 Schedule 13G/A passive filing 7.9%
  2. Empery Asset Management, LP filed Oct 13, 2026 Schedule 13G passive filing 8.73%
  3. CVI Investments, Inc. filed Aug 19, 2026 Schedule 13G passive filing 9.9%
  4. GMS Ventures & Investments filed Aug 14, 2026 Schedule 13D/A may seek influence 42,631,142 shares filing 16.4%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Notice of delisting or failure to meet a listing standard filing Sep 30, 2026
  2. Other events filing Sep 18, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.